产科抗磷脂综合征诊断与处理专家共识

2020-08-30 中华医学会围产医学分会 中华围产医学杂志.2020.23(8):517-522.

在抗磷脂抗体(antiphospholipid antibodies, aPLs) 持续性阳性情况下, 以病理妊娠为主要临床特征,伴或不伴血栓形成者,称为产科抗磷脂综合征(obstetric anti

中文标题:

产科抗磷脂综合征诊断与处理专家共识

发布日期:

2020-08-30

简要介绍:

在抗磷脂抗体(antiphospholipid antibodies, aPLs) 持续性阳性情况下, 以病理妊娠为主要临床特征,伴或不伴血栓形成者,称为产科抗磷脂综合征(obstetric antiphospholipid syndrome, OAPS)。OAPS 患者再次妊娠不良结局风险显著增加。妥善管理OAPS,可以有效改善妊娠结局。但OAPS 的诊断和治疗存在诸多争议,认识不足与过度诊疗现象共存。为规范OAPS 的临床管理,中华医学会围产医学分会组织相关专家撰写本专家共识。

下载附件:

(因为版权问题,不支持下载)

评论区 (18)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1199884, encodeId=e8dd119988458, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9EU2n1Rc4FEr2QicklnU0GaH4ouOn57Reu8dOL6vKyzOejT2H82xic4t56PmemlJxUC1eEwicz3A1F30LYDXB4iazw/132, createdBy=5ffa2447732, createdName=JXYJXY, createdTime=Sun Mar 06 11:51:37 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193751, encodeId=91721193e51be, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=782a5535518, createdName=ms2000001741529705, createdTime=Tue Feb 15 21:17:12 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193739, encodeId=433c1193e3923, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=782a5535518, createdName=ms2000001741529705, createdTime=Tue Feb 15 20:50:41 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996063, encodeId=f78999606399, content=收藏了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210704/5d4a8466672642d28b33e3d5b3663479/322c84f71fb64678b25ae0eb8aa2a266.jpg, createdBy=96692168438, createdName=1204889dm57暂无昵称, createdTime=Sun Jul 04 12:32:10 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996062, encodeId=f1e599606261, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210704/5d4a8466672642d28b33e3d5b3663479/322c84f71fb64678b25ae0eb8aa2a266.jpg, createdBy=96692168438, createdName=1204889dm57暂无昵称, createdTime=Sun Jul 04 12:32:03 CST 2021, time=2021-07-04, status=1, ipAttribution=)]
    2022-03-06 JXYJXY

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1199884, encodeId=e8dd119988458, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9EU2n1Rc4FEr2QicklnU0GaH4ouOn57Reu8dOL6vKyzOejT2H82xic4t56PmemlJxUC1eEwicz3A1F30LYDXB4iazw/132, createdBy=5ffa2447732, createdName=JXYJXY, createdTime=Sun Mar 06 11:51:37 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193751, encodeId=91721193e51be, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=782a5535518, createdName=ms2000001741529705, createdTime=Tue Feb 15 21:17:12 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193739, encodeId=433c1193e3923, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=782a5535518, createdName=ms2000001741529705, createdTime=Tue Feb 15 20:50:41 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996063, encodeId=f78999606399, content=收藏了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210704/5d4a8466672642d28b33e3d5b3663479/322c84f71fb64678b25ae0eb8aa2a266.jpg, createdBy=96692168438, createdName=1204889dm57暂无昵称, createdTime=Sun Jul 04 12:32:10 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996062, encodeId=f1e599606261, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210704/5d4a8466672642d28b33e3d5b3663479/322c84f71fb64678b25ae0eb8aa2a266.jpg, createdBy=96692168438, createdName=1204889dm57暂无昵称, createdTime=Sun Jul 04 12:32:03 CST 2021, time=2021-07-04, status=1, ipAttribution=)]
    2022-02-15 ms2000001741529705

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1199884, encodeId=e8dd119988458, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9EU2n1Rc4FEr2QicklnU0GaH4ouOn57Reu8dOL6vKyzOejT2H82xic4t56PmemlJxUC1eEwicz3A1F30LYDXB4iazw/132, createdBy=5ffa2447732, createdName=JXYJXY, createdTime=Sun Mar 06 11:51:37 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193751, encodeId=91721193e51be, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=782a5535518, createdName=ms2000001741529705, createdTime=Tue Feb 15 21:17:12 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193739, encodeId=433c1193e3923, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=782a5535518, createdName=ms2000001741529705, createdTime=Tue Feb 15 20:50:41 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996063, encodeId=f78999606399, content=收藏了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210704/5d4a8466672642d28b33e3d5b3663479/322c84f71fb64678b25ae0eb8aa2a266.jpg, createdBy=96692168438, createdName=1204889dm57暂无昵称, createdTime=Sun Jul 04 12:32:10 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996062, encodeId=f1e599606261, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210704/5d4a8466672642d28b33e3d5b3663479/322c84f71fb64678b25ae0eb8aa2a266.jpg, createdBy=96692168438, createdName=1204889dm57暂无昵称, createdTime=Sun Jul 04 12:32:03 CST 2021, time=2021-07-04, status=1, ipAttribution=)]
    2022-02-15 ms2000001741529705

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1199884, encodeId=e8dd119988458, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9EU2n1Rc4FEr2QicklnU0GaH4ouOn57Reu8dOL6vKyzOejT2H82xic4t56PmemlJxUC1eEwicz3A1F30LYDXB4iazw/132, createdBy=5ffa2447732, createdName=JXYJXY, createdTime=Sun Mar 06 11:51:37 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193751, encodeId=91721193e51be, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=782a5535518, createdName=ms2000001741529705, createdTime=Tue Feb 15 21:17:12 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193739, encodeId=433c1193e3923, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=782a5535518, createdName=ms2000001741529705, createdTime=Tue Feb 15 20:50:41 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996063, encodeId=f78999606399, content=收藏了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210704/5d4a8466672642d28b33e3d5b3663479/322c84f71fb64678b25ae0eb8aa2a266.jpg, createdBy=96692168438, createdName=1204889dm57暂无昵称, createdTime=Sun Jul 04 12:32:10 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996062, encodeId=f1e599606261, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210704/5d4a8466672642d28b33e3d5b3663479/322c84f71fb64678b25ae0eb8aa2a266.jpg, createdBy=96692168438, createdName=1204889dm57暂无昵称, createdTime=Sun Jul 04 12:32:03 CST 2021, time=2021-07-04, status=1, ipAttribution=)]
    2021-07-04 1204889dm57暂无昵称

    收藏了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1199884, encodeId=e8dd119988458, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9EU2n1Rc4FEr2QicklnU0GaH4ouOn57Reu8dOL6vKyzOejT2H82xic4t56PmemlJxUC1eEwicz3A1F30LYDXB4iazw/132, createdBy=5ffa2447732, createdName=JXYJXY, createdTime=Sun Mar 06 11:51:37 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193751, encodeId=91721193e51be, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=782a5535518, createdName=ms2000001741529705, createdTime=Tue Feb 15 21:17:12 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193739, encodeId=433c1193e3923, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=782a5535518, createdName=ms2000001741529705, createdTime=Tue Feb 15 20:50:41 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996063, encodeId=f78999606399, content=收藏了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210704/5d4a8466672642d28b33e3d5b3663479/322c84f71fb64678b25ae0eb8aa2a266.jpg, createdBy=96692168438, createdName=1204889dm57暂无昵称, createdTime=Sun Jul 04 12:32:10 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996062, encodeId=f1e599606261, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210704/5d4a8466672642d28b33e3d5b3663479/322c84f71fb64678b25ae0eb8aa2a266.jpg, createdBy=96692168438, createdName=1204889dm57暂无昵称, createdTime=Sun Jul 04 12:32:03 CST 2021, time=2021-07-04, status=1, ipAttribution=)]
    2021-07-04 1204889dm57暂无昵称

    学习了

    0